Pending EO 12866 Regulatory Review

RIN: 0910-ZC12	Received Date: 09/27/2024
Title: Considerations for Including Biopsies in Clinical Trials; Draft Guidance for Industry, Investigators, Institutions, and Institutional Review Boards
Agency/Subagency: HHS / FDA	Stage: Notice
Legal Deadline: None	Section 3(f)(1) Significant: No
International Impacts: No	Affordable Care Act [Pub. L. 111-148 & 111-152]: No
Pandemic Response: No	Dodd-Frank Wall Street Reform and Consumer Protection Act, [Pub. L. 111-203]: No